Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SEEMA S ACEVES

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1366511628
CMS profile
1142768
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$119,542.54

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$24,582.13

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $19,456.25 18
Acerta Pharma LLC $4,307.14 3
Regeneron Healthcare Solutions, Inc. $699.00 1
Takeda Pharmaceuticals U.S.A., Inc. $80.34 3
ABBVIE INC. $22.12 1
Grifols USA, LLC $17.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25.55 1
PY2019 $1,572.07 7
PY2020 $6,699.25 3
PY2021 $114.59 1
PY2022 $19,251.54 15
PY2023 $67,297.41 51
PY2024 $24,582.13 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.12 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103171114 CMS
AstraZeneca Pharmaceuticals LP $11.14 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105427978 CMS
AstraZeneca Pharmaceuticals LP $2,148.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1104342294 CMS
AstraZeneca Pharmaceuticals LP $2,148.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1105847395 CMS
GENZYME CORPORATION $1.30 02/16/2024 Food and Beverage Undisputed 01/23/2026 1139616462 CMS
GENZYME CORPORATION $44.89 02/16/2024 Food and Beverage Undisputed 01/23/2026 1139616464 CMS
GENZYME CORPORATION $7,913.00 04/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139616576 CMS
GENZYME CORPORATION $223.02 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1139616578 CMS
GENZYME CORPORATION $376.20 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1139616580 CMS
GENZYME CORPORATION $336.44 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1139616728 CMS
GENZYME CORPORATION $155.04 04/09/2024 Food and Beverage Undisputed 01/23/2026 1139616574 CMS
GENZYME CORPORATION $41.80 04/12/2024 Food and Beverage Undisputed 01/23/2026 1139616476 CMS
GENZYME CORPORATION $1.42 04/12/2024 Food and Beverage Undisputed 01/23/2026 1139616478 CMS
GENZYME CORPORATION $27.83 06/29/2024 Food and Beverage Undisputed 01/23/2026 1139616508 CMS
GENZYME CORPORATION $7,913.00 06/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139616542 CMS
GENZYME CORPORATION $957.42 06/29/2024 Travel and Lodging Undisputed 01/23/2026 1139616544 CMS
GENZYME CORPORATION $364.13 06/29/2024 Travel and Lodging Undisputed 01/23/2026 1139616546 CMS
GENZYME CORPORATION $850.16 06/29/2024 Travel and Lodging Undisputed 01/23/2026 1139616548 CMS
GENZYME CORPORATION $129.65 06/29/2024 Travel and Lodging Undisputed 01/23/2026 1139616744 CMS
GENZYME CORPORATION $45.44 07/12/2024 Food and Beverage Undisputed 01/23/2026 1139616510 CMS
GENZYME CORPORATION $49.31 09/13/2024 Food and Beverage Undisputed 01/23/2026 1139616552 CMS
GENZYME CORPORATION $26.20 10/04/2024 Food and Beverage Undisputed 01/23/2026 1139616562 CMS
Grifols USA, LLC $17.28 04/12/2024 Food and Beverage Undisputed 01/23/2026 1124744108 CMS
Regeneron Healthcare Solutions, Inc. $699.00 04/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1113994057 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.38 05/09/2024 Food and Beverage Undisputed 01/23/2026 1137460498 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.89 06/17/2024 Food and Beverage Undisputed 01/23/2026 1137460503 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.07 10/14/2024 Food and Beverage Undisputed 01/23/2026 1137460507 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.